Search research articles
Contact Us
Filters
Showing results (71-80 of 209) with videos related to
Page
of 21
Sort By:
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107
Przemyslaw W Twardowski, Catherine M Tangen, Xiwei Wu, et al.
Cancer
|
October 17, 2022
Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data
Daniel D Joyce, Kevin M Wymer, Vidit Sharma, et al.
The Oncologist
|
June 28, 2017
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors
Julia Judd, Matthew Zibelman, Elizabeth Handorf, et al.
The Journal of Urology
|
November 9, 2019
Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma
Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al.
The Journal of Urology
|
January 23, 2020
Reply by Authors
Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2014
Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors
Paul Haluska, Michael Menefee, Elizabeth R Plimack, et al.
Clinical Genitourinary Cancer
|
January 25, 2026
Preferred Treatment Sequencing for Metastatic Urothelial Carcinoma (mUC) in the Era of Perioperative and First-Line (1L) Checkpoint Inhibitor: Results From a National Survey of Genitourinary Oncologists
Karine Tawagi, Ali R Khaki, Priyanka V Chablani, et al.
Journal of Oncology Practice
|
June 23, 2016
Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer
Caitlin R Meeker, Daniel M Geynisman, Brian L Egleston, et al.
Urology
|
July 5, 2011
Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas
Daniel Canter, Jay Simhan, Marc C Smaldone, et al.
Urology
|
August 18, 2020
Assessing Contemporary Trends in Female Speakership within Urologic Oncology
Ruchika Talwar, Adrien Bernstein, Amanda Jones, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 209) with videos related to
Sort By:
Page
of 21
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107
Przemyslaw W Twardowski, Catherine M Tangen, Xiwei Wu, et al.
Cancer
|
October 17, 2022
Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data
Daniel D Joyce, Kevin M Wymer, Vidit Sharma, et al.
The Oncologist
|
June 28, 2017
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors
Julia Judd, Matthew Zibelman, Elizabeth Handorf, et al.
The Journal of Urology
|
November 9, 2019
Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma
Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al.
The Journal of Urology
|
January 23, 2020
Reply by Authors
Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2014
Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors
Paul Haluska, Michael Menefee, Elizabeth R Plimack, et al.
Clinical Genitourinary Cancer
|
January 25, 2026
Preferred Treatment Sequencing for Metastatic Urothelial Carcinoma (mUC) in the Era of Perioperative and First-Line (1L) Checkpoint Inhibitor: Results From a National Survey of Genitourinary Oncologists
Karine Tawagi, Ali R Khaki, Priyanka V Chablani, et al.
Journal of Oncology Practice
|
June 23, 2016
Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer
Caitlin R Meeker, Daniel M Geynisman, Brian L Egleston, et al.
Urology
|
July 5, 2011
Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas
Daniel Canter, Jay Simhan, Marc C Smaldone, et al.
Urology
|
August 18, 2020
Assessing Contemporary Trends in Female Speakership within Urologic Oncology
Ruchika Talwar, Adrien Bernstein, Amanda Jones, et al.
Page
of 21